Free Trial
NASDAQ:LIVN

LivaNova (LIVN) Stock Price, News & Analysis

LivaNova logo
$45.07 -1.60 (-3.43%)
As of 02:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About LivaNova Stock (NASDAQ:LIVN)

Key Stats

Today's Range
$44.79
$46.47
50-Day Range
$35.10
$47.60
52-Week Range
$32.48
$57.35
Volume
183,412 shs
Average Volume
635,726 shs
Market Capitalization
$2.46 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$59.29
Consensus Rating
Buy

Company Overview

LivaNova Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

LIVN MarketRank™: 

LivaNova scored higher than 63% of companies evaluated by MarketBeat, and ranked 342nd out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LivaNova has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    LivaNova has only been the subject of 4 research reports in the past 90 days.

  • Read more about LivaNova's stock forecast and price target.
  • Earnings Growth

    Earnings for LivaNova are expected to grow by 10.18% in the coming year, from $2.85 to $3.14 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LivaNova is -11.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LivaNova is -11.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    LivaNova has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about LivaNova's valuation and earnings.
  • Percentage of Shares Shorted

    4.08% of the float of LivaNova has been sold short.
  • Short Interest Ratio / Days to Cover

    LivaNova has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LivaNova has recently increased by 9.36%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    LivaNova does not currently pay a dividend.

  • Dividend Growth

    LivaNova does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.08% of the float of LivaNova has been sold short.
  • Short Interest Ratio / Days to Cover

    LivaNova has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LivaNova has recently increased by 9.36%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    LivaNova has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for LivaNova this week, compared to 6 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, LivaNova insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.29% of the stock of LivaNova is held by insiders.

  • Percentage Held by Institutions

    97.64% of the stock of LivaNova is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LivaNova's insider trading history.
Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

LIVN Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
LivaNova to Announce Second-Quarter 2025 Results
LivaNova: The Sell-Off Is Excessive Here
See More Headlines

LIVN Stock Analysis - Frequently Asked Questions

LivaNova's stock was trading at $46.31 at the beginning of 2025. Since then, LIVN stock has decreased by 2.6% and is now trading at $45.12.

LivaNova PLC (NASDAQ:LIVN) released its earnings results on Wednesday, May, 1st. The company reported $0.73 EPS for the quarter, topping the consensus estimate of $0.45 by $0.28. The business's revenue was up 12.0% on a year-over-year basis.
Read the conference call transcript
.

LivaNova's top institutional investors include Harbor Capital Advisors Inc. (0.19%), Wealth Enhancement Advisory Services LLC (0.02%), Central Pacific Bank Trust Division (0.01%) and Parallel Advisors LLC. Insiders that own company stock include Damien Mcdonald, Daniel Jeffrey Moore and Francesco Bianchi.
View institutional ownership trends
.

Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LivaNova investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
5/01/2024
Today
7/11/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:LIVN
CIK
1639691
Employees
2,900
Year Founded
N/A

Price Target and Rating

High Price Target
$64.00
Low Price Target
$55.00
Potential Upside/Downside
+27.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
16.38
P/E Growth
N/A
Net Income
$63.23 million
Net Margins
-17.41%
Pretax Margin
-15.14%
Return on Equity
13.67%
Return on Assets
6.68%

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
1.58
Quick Ratio
1.37

Sales & Book Value

Annual Sales
$1.25 billion
Price / Sales
2.03
Cash Flow
$4.20 per share
Price / Cash Flow
11.12
Book Value
$24.31 per share
Price / Book
1.92

Miscellaneous

Outstanding Shares
54,530,000
Free Float
54,368,000
Market Cap
$2.54 billion
Optionable
Optionable
Beta
0.90

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:LIVN) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners